ProActive Health® is Kerry's portfolio of clinically validated branded ingredients for digestive, immune, cognitive, and women's health, including Plenibiotic postbiotic (launched 2025) targeting digestive and skin health.
Each ingredient carries published clinical evidence meeting the standards for structure/function claims. The 2025 launch of Plenibiotic targets the emerging gut-skin axis. Kerry differentiates from pure-play ingredient suppliers by combining clinical health ingredients with its taste technology capabilities — e.g., taste-masking probiotics in gummy formats.
TRL 9 — established portfolio with ongoing expansion (Plenibiotic 2025) and clinical development pipeline.
Kerry is a global leader in taste and nutrition, providing integrated ingredient solutions for the food, beverage, and pharmaceutical industries. The company utilizes advanced biotechnology, sensory science, and consumer insights to help partners develop healthier, more sustainable, and better-tasting products. By focusing on nutritional optimization and functional ingredient performance, Kerry enables customers to solve complex challenges such as sugar reduction, texture improvement, and shelf-life extension.
With over 50 years of experience, Kerry partners with global brands to reach approximately 1.5 billion consumers annually. Their work supports critical industry needs, including product reformulation in response to shifting regulatory environments and consumer health demands. Through its focus on Sustainable Nutrition, the organization aims to improve the global food system while providing science-backed solutions that combine culinary ingenuity with clinical proof, driving value for both customers and long-term societal health.